Ipt Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.20 M
as on 17-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 12.08%
(FY 2022)
- Ebitda 162.08%
(FY 2022)
- Net Worth -4.63%
(FY 2022)
- Total Assets 58.35%
(FY 2022)
About Ipt Pharma
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Settipalli Sakuntaladevi and Venkateswara Gabbita serve as directors at the Company.
- CIN/LLPIN
U72900TN2020PTC135748
- Company No.
135748
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ipt Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Settipalli Sakuntaladevi  | Director | 12-Jun-2020 | Current |
| Venkateswara Gabbita | Director | 12-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Ipt Pharma.
Ipt Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.08% increase in profit. The company's net worth dipped by a decrease of 4.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ipt Pharma?
Unlock access to Ipt Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Info Plus Technologies Private LimitedActive 19 years 7 daysSettipalli Sakuntaladevi and Venkateswara Gabbita are mutual person
Kshiraja Dairy And Agri Private LimitedActive 4 years 2 monthsVenkateswara Gabbita is a mutual person
- Tirumala Hills Constructions Private LimitedActive 13 years 11 months
Venkateswara Gabbita is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ipt Pharma?
Ipt Pharma has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ipt Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipt Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
